Company Filing History:
1 out of 54 
1 out of 19 
1 out of 20 
Years Active: 2024
Title: Thomas Voit: Innovator in Gene Therapy for Dystrophic Muscle Pathologies
Introduction
Thomas Voit is a prominent inventor based in Boullay les Troux, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of dystrophic muscle pathologies. His innovative approach has the potential to transform the lives of individuals suffering from these conditions.
Latest Patents
Voit holds a patent for an "Efficient systemic treatment of dystrophic muscle pathologies." This patent describes a composition that comprises a gene therapy product for use in treating dystrophic diseases in subjects, particularly humans. The gene therapy product includes a nucleic acid sequence encoding a functional microdystrophin, and the composition is designed for systemic administration.
Career Highlights
Throughout his career, Thomas Voit has worked with notable organizations, including Genethon and Royal Holloway and Bedford New College. His work has focused on advancing the understanding and treatment of muscle diseases, making him a key figure in the field of medical research.
Collaborations
Voit has collaborated with esteemed colleagues such as George Dickson and Philippe Moullier. These partnerships have furthered research and development in gene therapy, contributing to the advancement of innovative treatments for muscle pathologies.
Conclusion
Thomas Voit is a distinguished inventor whose work in gene therapy is paving the way for new treatments for dystrophic muscle diseases. His contributions are vital to the ongoing research in this critical area of medicine.